Erratum: P53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population (Gastric Cancer DOI: 10.1007/s10120-011-0034-4);P53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population

Gastric Cancer

Volumn 14, Issue 3, 2011, Pages 242-247

  Song, Hye Rim ^a,b   Kweon, Sun Seog ^a,b   Kim, Hee Nam ^b   Piao, Jin Mei ^a,c   Yun, Woo Jun ^a   Choi, Jin Su ^a   Hwang, Jun Eul ^a   Yoon, Ju Young ^a   Kim, Hyeong Rok ^b   Park, Young Kyu ^b   Kim, Soo Hyun ^a   Choi, Yoo Duk ^a   Shin, Min Ho ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

^c YANBIAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; Gastric cancer; P53 codon 72 polymorphism

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASIAN; CANCER PATIENT; CANCER RISK; CIGARETTE SMOKING; CODON; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; KOREAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

EID: 80053908168     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0077-6     Document Type: Erratum

References (31)

1. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell. 2004;5(2):121-5. (Pubitemid 38283798)
2. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354-62. (Pubitemid 43329250)
3. Goh KL, Quek KF, Yeo GT, Hilmi IN, Lee CK, Hasnida N, et al. Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy. Aliment Pharmacol Ther. 2005;22(9):859-64. (Pubitemid 41564366)
4. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119(5):265-72. (Pubitemid 23055428)
5. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525-32.
6. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759-67.
7. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408(6810):307-10.
8. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol. 2007;8(4):275-83. (Pubitemid 46474662)
9. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002;2(8):594-604. (Pubitemid 37328926)
10. Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, et al. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology. 2000;118(6):1039-44. (Pubitemid 30346980)
11. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, et al. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell. 2003;3(4):387-402. (Pubitemid 38340307)
12. Li Y, Prives C. Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? Oncogene. 2007;26(15): 2220-5. (Pubitemid 46536648)
13. Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA. 1996;93(26):15335-40. (Pubitemid 27009601)
14. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matla-shewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19(2):1092-100. (Pubitemid 29046852)
15. Katkoori VR, Jia X, Shanmugam C, Wan W, Meleth S, Bumpers H, et al. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res. 2009;15(7):2406-16.
16. Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, et al. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep. 2004;11(5):1115-20.
17. Yi SY, Lee WJ. A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer. World J Gastroenterol. 2006;12(40):6536-9. (Pubitemid 44742591)
18. Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, et al. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer. 2006;119(8):1863-8. (Pubitemid 44356844)
19. Zhu ZZ, Wang AZ, Jia HR, Jin XX, He XL, Hou LF, et al. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol. 2007;37(5): 385-90.
20. Sul J, GP Yu, QY Lu, ML Lu, Setiawan VW, Wang MR, et al. P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions. Cancer Lett. 2006;238(2): 210-23. (Pubitemid 43884957)
21. Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, et al. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer. 2005;116(6):972-83. (Pubitemid 41209206)
22. Perez-Perez GI, Bosques-Padilla FJ, Crosatti ML, Tijerina-Menchaca R, Garza-Gonzalez E. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol. 2005;40(1):56-60.
23. Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Hatooka S, et al. No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett. 2002;181(1): 81-5. (Pubitemid 34326437)
24. Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, et al. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer. 2002;100(3):304-8. (Pubitemid 34728988)
25. Wu MT, Chen MC, Wu DC. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan. Cancer Lett. 2004;205(1):61-8.
26. Lai KC, Chen WC, Tsai FJ, Li SY, Jeng LB. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer. Hepatogastroenterology. 2005;52(63):944-8.
27. Chung WC, Lee KM, Lee BI, Chun JS, Lee SY, Chang UI, et al. P53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med. 2006;21(1):28-32. (Pubitemid 43732763)
28. Perez LO, Abba MC, Dulout FN, Golijow CD. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J Gastroenterol. 2006;12(9): 1426-9.
29. Dakouras A, Nikiteas N, Papadakis E, Perakis M, Valis D, Rallis G, et al. P53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek-Caucasian population. Anticancer Res. 2008;28(2A):1039-43. (Pubitemid 351578952)
30. Mammano E, Belluco C, Bonafe M, Olivieri F, Mugianesi E, Barbi C, et al. Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression. Eur J Surg Oncol. 2009;35(4):415-9.
31. Gemignani F, Moreno V, Landi S, Moullan N, Chabrier A, Gutierrez-Enriquez S, et al. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene. 2004;23(10):1954-6. (Pubitemid 38445422)